Skip to main content
Veterinary Medicines

AviTuberculin 30 000 suspenzia na intradermálnu aplikáciu

Authorised
  • TUBERCULINUM AVIAIRE

Product identification

Medicine name:
AviTuberculin 30 000 suspenzia na intradermálnu aplikáciu
Active substance:
  • TUBERCULINUM AVIAIRE
Target species:
  • Cattle
  • Pig
  • Horse
  • Sheep
  • Goat
Route of administration:
  • Intradermal use
  • Intradermal use
  • Intradermal use
  • Intradermal use
  • Intradermal use

Product details

Active substance and strength:
  • TUBERCULINUM AVIAIRE
    30000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intradermal use
    • Cattle
      • All relevant tissues
        0
        day
  • Intradermal use
    • Pig
      • All relevant tissues
        0
        day
  • Intradermal use
    • Horse
      • All relevant tissues
        0
        day
  • Intradermal use
    • Sheep
      • All relevant tissues
        0
        day
  • Intradermal use
    • Goat
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AS
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Pharmagal Bio spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmagal Bio spol. s r.o.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/104/01-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 19/11/2021
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."